Janus Henderson Global Life Sciences Fund Class S
Janus Henderson Global Life Sciences Fund Class S Fundamental Analysis
Janus Henderson Global Life Sciences Fund Class S (JFNSX) shows weak financial fundamentals with a PE ratio of N/A, profit margin of N/A, and ROE of N/A. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 0.0/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze JFNSX's fundamental strength across five key dimensions:
Efficiency Score
WeakJFNSX struggles to generate sufficient returns from assets.
Valuation Score
WeakJFNSX trades at a premium to fair value.
Growth Score
WeakJFNSX faces weak or negative growth trends.
Financial Health Score
WeakJFNSX carries high financial risk with limited liquidity.
Profitability Score
WeakJFNSX struggles to sustain strong margins.
Key Financial Metrics
Is JFNSX Expensive or Cheap?
No data available.
How Well Does JFNSX Make Money?
No data available.
Following the Money - Real Cash Generation
No data available.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
N/A
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
N/A
vs 25 benchmark
P/B Ratio
Price to book value ratio
N/A
vs 25 benchmark
P/S Ratio
Price to sales ratio
N/A
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
N/A
vs 25 benchmark
Current Ratio
Current assets to current liabilities
N/A
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
N/A
vs 25 benchmark
ROA
Return on assets percentage
N/A
vs 25 benchmark
ROCE
Return on capital employed
N/A
vs 25 benchmark
How JFNSX Stacks Against Its Sector Peers
| Metric | JFNSX Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | N/A | 18.86 | N/A |
| ROE | N/A | 847.00% | N/A |
| Net Margin | N/A | 4202.00% | N/A |
| Debt/Equity | N/A | 0.91 | N/A |
| Current Ratio | N/A | 667.17 | N/A |
| ROA | N/A | -21543.00% (disorted) | N/A |
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Janus Henderson Global Life Sciences Fund Class S's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Value, Dividend, Cyclical
EPS CAGR
N/A
Industry Style: Value, Dividend, Cyclical
FCF CAGR
N/A
Industry Style: Value, Dividend, Cyclical